<DOC>
	<DOCNO>NCT03059537</DOCNO>
	<brief_summary>This study aim validate possible diagnostic test bile acid diarrhoea prospectively compare SeHCAT scintigraphy . Fasting participant give standard meal 1,250 mg chenodeoxycholic acid . The investigator measure fast FGF19 , bile acid specie include 7-alpha-CHO serial blood sample stimulation .</brief_summary>
	<brief_title>Validation Stimulated âˆ†FGF19 Diagnosing Bile Acid Diarrhoea</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Malabsorption Syndromes</mesh_term>
	<mesh_term>Chenodeoxycholic Acid</mesh_term>
	<mesh_term>Bile Acids Salts</mesh_term>
	<criteria>Consecutive patient refer SeHCAT Treatment sequestrants within one week SeHCAT . Treatment constipants/laxatives one day SeHCAT , exception opioids , dosis stable prior 2 week . Pregnancy , screen pregnancy test inclusion . Breastfeeding woman . Small bowel resection , include right side hemicolectomy . Any ongoing treatment inflammatory bowel disease systemic steroid ( i.e . budesonide prednisone ) treatment prior 4 week . Allergies constituent Xenbilox : ( chenodeoxycholic acid , cornflour , magnesium stearate , highly disperse silica , gelatine , sodium dodecylsulphate , titanium dioxide ( E171 ) , quinolone yellow ( E104 ) , erythrosine ( E127 ) Chronic acute cholecystitis . Liver cirrhosis , Obstructed bile flow cause jaundice elevate pbilirubin ( &gt; 1,5 UNL ) . Known disability gall bladder contractility . Bile duct atresia . Frequent gallstone attack ( &gt; 2/month ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>